Wegovy and Ozempic owner dealt blow as next-gen weight-loss drug is labelled ‘obsolete’
The owner of Wegovy and Ozempic has suffered a significant setback, as its highly anticipated new weight-loss treatment was labelled “obsolete” after disappointing clinical trials.Novo Nordisk’s shares fell sharply on Monday after the…